JOSHUA PAN: Open Payments
NPI 1972113074 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,807 in 41 payments from 10 companies in 2025. Trend: 2023 $2,049 · 2024 $1,370 · 2025 $1,807
Food & beverage: $1,548Education: $259
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 7 | $404 |
| Botanix SB Inc | 2 | $309 |
| Incyte Corporation | 4 | $271 |
| E.R. Squibb & Sons, L.L.C. | 12 | $205 |
| Galderma Laboratories, L.P. | 5 | $156 |
| UCB, Inc. | 4 | $155 |
| Lilly USA, LLC | 1 | $120 |
| Regeneron Healthcare Solutions, Inc. | 1 | $96 |
| ABBVIE INC. | 4 | $64 |
| Organon LLC | 1 | $28 |
Products named: TREMFYA, SOFDRA, OPZELURA, Sotyktu, Bimzelx, AKLIEF, EBGLYSS, DUPIXENT.
Industry payments across VA — which companies pay providers there.
